Viviscal – the leading dietary supplement for hair loss/fine thinning hair worldwide – has announced the results of their 6th clinical trial.
The company’s first clinical trial to focus only on women and the double-blind, placebo-controlled study showed positive results in promoting significant hair growth in women with temporary hair thinning or hair loss.
The renowned dermatologist and founder of the Ablon Skin Institute Research Center, Glynis Ablon, MD, FAAD, evaluated the efficacy of an oral supplement on healthy women women between the ages of 21 to 75 who perceived their hair was thinning.
Made in Finland, Viviscal Professional is a specially formulated dietary supplement that contains a concentrate of the brand’s exclusive AminoMar CTM Marine Complex. Viviscal Professional nourishes thinning hair from the inside and encourages existing hair growth in those suffering from temporary hair loss.
The study showed an increase of baseline hairs by almost 67% after 180 days in participants using Viviscal Professional, while control-treated subjects saw improvements in overall hair volume, scalp coverage, and thickness of hair body after 90 days. Additional improvement after 180 days included hair shine, skin moisture retention, and skin smoothness, while no adverse effects were reported.
“Hair loss affects one in two men and one in three women in the United States, making it a common concern for millions of people,” said Mark Holland, US President of Lifes2Good, the natural health care company that owns Viviscal. “We take our products and results seriously and this new clinical trial underscores the product’s efficacy. The before-and-after results truly speak for themselves. “
Viviscal Professional is available only in fine salons, spas and dermatology offices.
For more information on the Viviscal Professional product line, please visit http://www.viviscalpro.com